We are live on ! Find out more
HURA

TuHURA Biosciences

7 hedge funds and large institutions have $3.06M invested in TuHURA Biosciences in 2017 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more funds holding

Funds holding: 37 (+4)

0% more ownership

Funds ownership: 0%0% (+0%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

29% less capital invested

Capital invested by funds: $4.28M → $3.06M (-$1.22M)

Holders
7
Holders Change
+4
Holders Change %
+133.33%
% of All Funds
0.17%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
4
Increased
1
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change

HURA Hedge Fund Activity: Q3 2017 in Review

7 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q3 2017, worth a combined $3.06M — down 29% from $4.28M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new HURA positions and 0 closed out — a net gain of 4 holders — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Sabby Management, adding an estimated $2.3M. The largest seller was Raymond James Financial Services Advisors, cutting an estimated $164K.

  • 7 institutional investors held TuHURA Biosciences (HURA) as of Q3 2017, up from 3 in Q2 2017.
  • Funds reported $3.06M of TuHURA Biosciences stock for Q3 2017, down 29% quarter-over-quarter.
  • 4 funds opened new TuHURA Biosciences positions in Q3 2017 and 0 closed out, a net change of +4 holders.
  • The largest TuHURA Biosciences buyer in Q3 2017 was Sabby Management, an estimated $2.3M added.
  • The largest TuHURA Biosciences seller in Q3 2017 was Raymond James Financial Services Advisors, an estimated $164K sold.

Based on aggregated 13F filings for Q3 2017.